Tbo-filgrastim
Tbo-filgrastim
Tbo-filgrastim (/ˈtiːboʊ fɪlˈɡræstɪm/) is a biopharmaceutical drug used to stimulate the production of neutrophils, a type of white blood cell that plays a significant role in the body's response to infection.
Etymology
The name "Tbo-filgrastim" is derived from the original name of the drug, "filgrastim", with the prefix "Tbo-" added to distinguish it from other filgrastim products. "Filgrastim" itself is derived from the term "granulocyte colony-stimulating factor" (G-CSF), which describes the drug's function.
Usage
Tbo-filgrastim is used to treat neutropenia, a condition characterized by an abnormally low number of neutrophils. This condition is often a side effect of chemotherapy treatment for cancer. By stimulating the production of neutrophils, Tbo-filgrastim helps to reduce the risk of infection in patients undergoing chemotherapy.
Related Terms
- Neutropenia: A condition characterized by an abnormally low number of neutrophils.
- Neutrophil: A type of white blood cell that plays a significant role in the body's response to infection.
- Biopharmaceutical: A type of drug produced using biotechnology.
- Chemotherapy: A type of cancer treatment that uses drugs to kill cancer cells.
See Also
External links
- Medical encyclopedia article on Tbo-filgrastim
- Wikipedia's article - Tbo-filgrastim
This WikiMD article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski